At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
Dexmedetomidine +1 moredrug
Likely dose
Dexmedetomidine 1.0 μgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Dexmedetomidine as an Adjuvant on the Median Effective Concentration of Lidocaine for Obturator Nerve Block - A Perspective, Randomized，Blind Study
In Brief
A clinical study evaluating Dexmedetomidine and Normal Saline for Nerve Block. Completed, enrolled 60 participants across 1 site.
Detailed Summary
Hypothesis: Dexmedetomidine as an adjuvant of lidocaine can decrease the median effective concentration(EC50) of lidocaine for obturator nerve block during transurethral resection of bladder tumor
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNerve Block
CountriesChina
CollaboratorsTianjin Medical University General Hospital
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2014
First PostedFeb 2014
Primary CompletionApr 2014
Study CompletionMay 2014
TodayJul 2026
First PostedFeb 19, 2014
Enrollment StartFeb 1, 2014
Primary CompletionApr 1, 2014
Study CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 12.4 years ago
Interventions
Dexmedetomidinedrug
Dexmedetomidine is administrated as an adjuvant of lidocaine at a dose of 1.0 μg/ kg.
Normal Salinedrug
Normal Saline is administrated as an adjuvant of lidocaine.